Cargando…

Quantitative Analysis for the Delineation of the Subthalamic Nuclei on Three-Dimensional Stereotactic MRI Before Deep Brain Stimulation Surgery for Medication-Refractory Parkinson’s Disease

Delineation of the subthalamic nuclei (STN) on MRI is critical for deep brain stimulation (DBS) surgery in patients with Parkinson’s disease (PD). We propose this retrospective cohort study for quantitative analysis of MR signal-to-noise ratio (SNR), contrast, and signal difference-to-noise ratio (S...

Descripción completa

Detalles Bibliográficos
Autores principales: Su, Chun-Yu, Wong, Alex Mun-Ching, Chang, Chih-Chen, Tu, Po-Hsun, Chen, Chiung Chu, Yeh, Chih-Hua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8902041/
https://www.ncbi.nlm.nih.gov/pubmed/35273486
http://dx.doi.org/10.3389/fnhum.2022.829198
_version_ 1784664505498730496
author Su, Chun-Yu
Wong, Alex Mun-Ching
Chang, Chih-Chen
Tu, Po-Hsun
Chen, Chiung Chu
Yeh, Chih-Hua
author_facet Su, Chun-Yu
Wong, Alex Mun-Ching
Chang, Chih-Chen
Tu, Po-Hsun
Chen, Chiung Chu
Yeh, Chih-Hua
author_sort Su, Chun-Yu
collection PubMed
description Delineation of the subthalamic nuclei (STN) on MRI is critical for deep brain stimulation (DBS) surgery in patients with Parkinson’s disease (PD). We propose this retrospective cohort study for quantitative analysis of MR signal-to-noise ratio (SNR), contrast, and signal difference-to-noise ratio (SDNR) of the STN on pre-operative three-dimensional (3D) stereotactic MRI in patients with medication-refractory PD. Forty-five consecutive patients with medication-refractory PD who underwent STN-DBS surgery in our hospital from January 2018 to June 2021 were included in this study. All patients had whole-brain 3D MRI, including T2-weighted imaging (T2WI), T2-weighted fluid-attenuated inversion recovery (FLAIR), and susceptibility-weighted imaging (SWI), at 3.0 T scanner for stereotactic navigation. The signal intensities of the STN, corona radiata, and background noise were obtained after placing regions of interest (ROIs) on corresponding structures. Quantitative comparisons of SNR, contrast, and SDNR of the STN between MR pulse sequences, including the T2WI, FLAIR, and SWI. Subgroup analysis regarding patients’ sex, age, and duration of treatment. We used one-way repeated measures analysis of variance for quantitative comparisons of SNR, contrast, and SDNR of the STN between different MR pulse sequences, and we also used the dependent t-test for the post hoc tests. In addition, we used Mann–Whitney U test for subgroup analyses. Both the contrast (0.33 ± 0.07) and SDNR (98.65 ± 51.37) were highest on FLAIR (all p < 0.001). The SNR was highest on SWI (276.16 ± 115.5), and both the SNR (94.23 ± 31.63) and SDNR (32.14 ± 17.23) were lowest on T2WI. Subgroup analyses demonstrated significantly lower SDNR on SWI for patients receiving medication treatment for ≥13 years (p = 0.003). In conclusion, on 3D stereotactic MRI of medication-refractory PD patients, the contrast and SDNR for the STN are highest on FLAIR, suggesting the optimal delineation of STN on FLAIR.
format Online
Article
Text
id pubmed-8902041
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-89020412022-03-09 Quantitative Analysis for the Delineation of the Subthalamic Nuclei on Three-Dimensional Stereotactic MRI Before Deep Brain Stimulation Surgery for Medication-Refractory Parkinson’s Disease Su, Chun-Yu Wong, Alex Mun-Ching Chang, Chih-Chen Tu, Po-Hsun Chen, Chiung Chu Yeh, Chih-Hua Front Hum Neurosci Neuroscience Delineation of the subthalamic nuclei (STN) on MRI is critical for deep brain stimulation (DBS) surgery in patients with Parkinson’s disease (PD). We propose this retrospective cohort study for quantitative analysis of MR signal-to-noise ratio (SNR), contrast, and signal difference-to-noise ratio (SDNR) of the STN on pre-operative three-dimensional (3D) stereotactic MRI in patients with medication-refractory PD. Forty-five consecutive patients with medication-refractory PD who underwent STN-DBS surgery in our hospital from January 2018 to June 2021 were included in this study. All patients had whole-brain 3D MRI, including T2-weighted imaging (T2WI), T2-weighted fluid-attenuated inversion recovery (FLAIR), and susceptibility-weighted imaging (SWI), at 3.0 T scanner for stereotactic navigation. The signal intensities of the STN, corona radiata, and background noise were obtained after placing regions of interest (ROIs) on corresponding structures. Quantitative comparisons of SNR, contrast, and SDNR of the STN between MR pulse sequences, including the T2WI, FLAIR, and SWI. Subgroup analysis regarding patients’ sex, age, and duration of treatment. We used one-way repeated measures analysis of variance for quantitative comparisons of SNR, contrast, and SDNR of the STN between different MR pulse sequences, and we also used the dependent t-test for the post hoc tests. In addition, we used Mann–Whitney U test for subgroup analyses. Both the contrast (0.33 ± 0.07) and SDNR (98.65 ± 51.37) were highest on FLAIR (all p < 0.001). The SNR was highest on SWI (276.16 ± 115.5), and both the SNR (94.23 ± 31.63) and SDNR (32.14 ± 17.23) were lowest on T2WI. Subgroup analyses demonstrated significantly lower SDNR on SWI for patients receiving medication treatment for ≥13 years (p = 0.003). In conclusion, on 3D stereotactic MRI of medication-refractory PD patients, the contrast and SDNR for the STN are highest on FLAIR, suggesting the optimal delineation of STN on FLAIR. Frontiers Media S.A. 2022-02-22 /pmc/articles/PMC8902041/ /pubmed/35273486 http://dx.doi.org/10.3389/fnhum.2022.829198 Text en Copyright © 2022 Su, Wong, Chang, Tu, Chen and Yeh. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neuroscience
Su, Chun-Yu
Wong, Alex Mun-Ching
Chang, Chih-Chen
Tu, Po-Hsun
Chen, Chiung Chu
Yeh, Chih-Hua
Quantitative Analysis for the Delineation of the Subthalamic Nuclei on Three-Dimensional Stereotactic MRI Before Deep Brain Stimulation Surgery for Medication-Refractory Parkinson’s Disease
title Quantitative Analysis for the Delineation of the Subthalamic Nuclei on Three-Dimensional Stereotactic MRI Before Deep Brain Stimulation Surgery for Medication-Refractory Parkinson’s Disease
title_full Quantitative Analysis for the Delineation of the Subthalamic Nuclei on Three-Dimensional Stereotactic MRI Before Deep Brain Stimulation Surgery for Medication-Refractory Parkinson’s Disease
title_fullStr Quantitative Analysis for the Delineation of the Subthalamic Nuclei on Three-Dimensional Stereotactic MRI Before Deep Brain Stimulation Surgery for Medication-Refractory Parkinson’s Disease
title_full_unstemmed Quantitative Analysis for the Delineation of the Subthalamic Nuclei on Three-Dimensional Stereotactic MRI Before Deep Brain Stimulation Surgery for Medication-Refractory Parkinson’s Disease
title_short Quantitative Analysis for the Delineation of the Subthalamic Nuclei on Three-Dimensional Stereotactic MRI Before Deep Brain Stimulation Surgery for Medication-Refractory Parkinson’s Disease
title_sort quantitative analysis for the delineation of the subthalamic nuclei on three-dimensional stereotactic mri before deep brain stimulation surgery for medication-refractory parkinson’s disease
topic Neuroscience
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8902041/
https://www.ncbi.nlm.nih.gov/pubmed/35273486
http://dx.doi.org/10.3389/fnhum.2022.829198
work_keys_str_mv AT suchunyu quantitativeanalysisforthedelineationofthesubthalamicnucleionthreedimensionalstereotacticmribeforedeepbrainstimulationsurgeryformedicationrefractoryparkinsonsdisease
AT wongalexmunching quantitativeanalysisforthedelineationofthesubthalamicnucleionthreedimensionalstereotacticmribeforedeepbrainstimulationsurgeryformedicationrefractoryparkinsonsdisease
AT changchihchen quantitativeanalysisforthedelineationofthesubthalamicnucleionthreedimensionalstereotacticmribeforedeepbrainstimulationsurgeryformedicationrefractoryparkinsonsdisease
AT tupohsun quantitativeanalysisforthedelineationofthesubthalamicnucleionthreedimensionalstereotacticmribeforedeepbrainstimulationsurgeryformedicationrefractoryparkinsonsdisease
AT chenchiungchu quantitativeanalysisforthedelineationofthesubthalamicnucleionthreedimensionalstereotacticmribeforedeepbrainstimulationsurgeryformedicationrefractoryparkinsonsdisease
AT yehchihhua quantitativeanalysisforthedelineationofthesubthalamicnucleionthreedimensionalstereotacticmribeforedeepbrainstimulationsurgeryformedicationrefractoryparkinsonsdisease